These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30637839)

  • 41. Biological dosimetry for breast cancer radiotherapy: a comparison of external beam and intraoperative radiotherapy.
    Woolf DK; Williams NR; Bakshi R; Madani SY; Eaton DJ; Fawcitt S; Pigott K; Short S; Keshtgar M
    Springerplus; 2014; 3():329. PubMed ID: 25045612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health-related quality of life of breast cancer patients after accelerated partial breast irradiation using intraoperative or external beam radiotherapy technique.
    Jacobs DHM; Horeweg N; Straver M; Roeloffzen EMA; Speijer G; Merkus J; van der Sijp J; Mast ME; Fisscher U; Petoukhova AL; Zwanenburg AG; Marijnen CAM; Koper PCM
    Breast; 2019 Aug; 46():32-39. PubMed ID: 31075670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer.
    Hashemi S; Javadi S; Akbari ME; Mirzaei H; Mahdavi SR
    Int J Surg Oncol; 2021; 2021():2476527. PubMed ID: 33953982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial.
    Keshtgar MR; Williams NR; Bulsara M; Saunders C; Flyger H; Cardoso JS; Corica T; Bentzon N; Michalopoulos NV; Joseph DJ
    Breast Cancer Res Treat; 2013 Aug; 140(3):519-25. PubMed ID: 23877341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraoperative radiotherapy in elderly patients with breast cancer: Is there a clinical applicability? Review of the current evidence.
    Esposito E; Compagna R; Rinaldo M; Falivene S; Ravo V; Amato B; Muto P; D'Aiuto M
    Int J Surg; 2016 Sep; 33 Suppl 1():S88-91. PubMed ID: 27255125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan.
    Lai HW; Liu LC; Ouyang F; Yao CC; Jan HC; Chang YH; Tu CW; Chen DR; Cheng TF; Tzeng YD; Hsu HM; Yeh MH; Wu YC; Yang PS; Lam HB; Hou MF; Chen FM
    PLoS One; 2017; 12(11):e0185876. PubMed ID: 29095832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option?
    Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA
    Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes and complications of intraoperative radiotherapy versus external beam radiotherapy for early breast cancer.
    Zangouri V; Roshanshad A; Ranjbar A; Izadi M; Rajaeifar S; Goodarzi A; Nasrollahi H
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1950. PubMed ID: 38205671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.
    Valente SA; Tendulkar RD; Cherian S; O'Rourke C; Greif JM; Bailey L; Uhl V; Bethke KP; Donnelly ED; Rudolph R; Pederson A; Summer T; Lottich SC; Ross DL; Laronga C; Loftus L; Abbott AM; Kelemen P; Hermanto U; Friedman NB; Bedi GC; Joh JE; Thompson WA; Hoefer RA; Wilson JP; Kang SK; Rosen B; Ruffer J; Bravo L; Police A; Escallon JM; Fyles AW; McCready DR; Graves GM; Rohatgi N; Eaker JA; Graves J; Willey SC; Tousimis EA; Collins BT; Shaw CM; Riley L; Deb N; Kelly T; Andolino DL; Boisvert ME; Lyons J; Small W; Grobmyer SR
    Ann Surg Oncol; 2016 Sep; 23(9):2809-15. PubMed ID: 27160524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 1--ELIOT.
    Silverstein MJ; Fastner G; Maluta S; Reitsamer R; Goer DA; Vicini F; Wazer D
    Ann Surg Oncol; 2014 Nov; 21(12):3787-92. PubMed ID: 25160734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Schoeber C; Schaefer J; Steil V; Wenz F
    BMC Cancer; 2007 Sep; 7():178. PubMed ID: 17854511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraoperative radiotherapy (IORT) as boost in breast cancer.
    Sedlmayer F; Reitsamer R; Wenz F; Sperk E; Fussl C; Kaiser J; Ziegler I; Zehentmayr F; Deutschmann H; Kopp P; Fastner G
    Radiat Oncol; 2017 Jan; 12(1):23. PubMed ID: 28103903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on intraoperative radiotherapy: new challenges and issues.
    Esposito E; Douek M
    Ecancermedicalscience; 2018; 12():793. PubMed ID: 29434659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).
    Goerdt L; Schnaubelt R; Kraus-Tiefenbacher U; Brück V; Bauer L; Dinges S; von der Assen A; Meye H; Kaiser C; Weiss C; Clausen S; Schneider F; Abo-Madyan Y; Fleckenstein K; Berlit S; Tuschy B; Sütterlin M; Wenz F; Sperk E
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraoperative radiotherapy as an immediate adjuvant treatment of rectal cancer due to limited access to external-beam radiotherapy.
    Potemin S; Kübler J; Uvarov I; Wenz F; Giordano F
    Radiat Oncol; 2020 Jan; 15(1):11. PubMed ID: 31924250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk-Stratified Intraoperative Radiation Therapy as a Definitive Adjuvant Radiation Therapy Modality for Women With Early Breast Cancer.
    Small W; Refaat T; Feldman SM; Holmes D
    Pract Radiat Oncol; 2022; 12(4):320-323. PubMed ID: 35717048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems.
    Vaidya JS; Vaidya UJ; Baum M; Bulsara MK; Joseph D; Tobias JS
    Front Oncol; 2022; 12():786515. PubMed ID: 36033486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment.
    Vaidya JS; Bulsara M; Baum M; Tobias JS;
    Br J Cancer; 2021 Apr; 124(9):1469-1474. PubMed ID: 33531693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
    Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
    Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.